EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 1 filers reported holding EVELO BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $572,525 | -88.8% | 3,168,375 | 0.0% | 0.00% | – |
Q4 2022 | $5,101,084 | -24.3% | 3,168,375 | -1.7% | 0.00% | – |
Q3 2022 | $6,735,000 | +134.7% | 3,222,420 | +136.9% | 0.00% | – |
Q2 2022 | $2,870,000 | -45.2% | 1,360,322 | -11.9% | 0.00% | – |
Q1 2022 | $5,235,000 | -38.9% | 1,544,518 | +9.4% | 0.00% | – |
Q4 2021 | $8,571,000 | -18.6% | 1,411,816 | -5.6% | 0.00% | – |
Q3 2021 | $10,532,000 | -48.1% | 1,495,887 | +1.3% | 0.00% | -100.0% |
Q2 2021 | $20,291,000 | +40.1% | 1,476,784 | +9.1% | 0.00% | – |
Q1 2021 | $14,479,000 | +3.8% | 1,353,224 | +17.3% | 0.00% | – |
Q4 2020 | $13,952,000 | +198.5% | 1,154,066 | +30.1% | 0.00% | – |
Q3 2020 | $4,674,000 | +9.3% | 886,960 | +1.6% | 0.00% | – |
Q2 2020 | $4,277,000 | +167.0% | 873,054 | +104.6% | 0.00% | – |
Q1 2020 | $1,602,000 | -7.3% | 426,712 | +0.2% | 0.00% | – |
Q4 2019 | $1,729,000 | -33.8% | 425,768 | -0.5% | 0.00% | – |
Q3 2019 | $2,610,000 | -33.2% | 427,915 | -1.7% | 0.00% | – |
Q2 2019 | $3,909,000 | +13.2% | 435,335 | +0.9% | 0.00% | – |
Q1 2019 | $3,453,000 | -15.5% | 431,650 | +37.5% | 0.00% | – |
Q4 2018 | $4,084,000 | +39.9% | 313,869 | +30.9% | 0.00% | – |
Q3 2018 | $2,920,000 | +269.6% | 239,792 | +258.0% | 0.00% | – |
Q2 2018 | $790,000 | – | 66,988 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 22,577 | $88,502 | 0.17% |